Y, Z., L, C., W, C., D, Y., L, Z., & J, L. (2025). Liquid chromatography-tandem mass spectrometry assay for the simultaneous determination of apalutamide and its active metabolite N-desmethyl apalutamide, and its application in real-world patients with castration-resistant prostate cancer. Frontiers in pharmacology, 16, 1510583. https://doi.org/10.3389/fphar.2025.1510583
Chicago Style (17th ed.) CitationY, Zhu, Chen L, Cheng W, Yang D, Zhang L, and Li J. "Liquid Chromatography-tandem Mass Spectrometry Assay for the Simultaneous Determination of Apalutamide and Its Active Metabolite N-desmethyl Apalutamide, and Its Application in Real-world Patients with Castration-resistant Prostate Cancer." Frontiers in Pharmacology 16 (2025): 1510583. https://doi.org/10.3389/fphar.2025.1510583.
MLA (9th ed.) CitationY, Zhu, et al. "Liquid Chromatography-tandem Mass Spectrometry Assay for the Simultaneous Determination of Apalutamide and Its Active Metabolite N-desmethyl Apalutamide, and Its Application in Real-world Patients with Castration-resistant Prostate Cancer." Frontiers in Pharmacology, vol. 16, 2025, p. 1510583, https://doi.org/10.3389/fphar.2025.1510583.
